🕵️ Tarsus Pharmaceuticals, Inc. ($TARS)
SEC insider & ownership activity, last 12 months · CIK 1819790 · every row links its SEC filing
Over the last 12 months insiders sold $16.9M with no open-market buying against it. Link William J Phd sold $5.0M (Sep–Jun). No red-flag 8-Ks in the window.
🚨 17 signals active —
planned-vs-executed verdicts, pre-event flags, and cluster context live in the
API and the
alerts bot.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 9 sellers, $16.9M (48 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Link William J Phd | 0 | – | 11 | $5.0M | Jun 15, 2026 |
| Bobak R. Azamian | 0 | – | 9 | $4.1M | Jun 17, 2026 |
| Dianne C. Whitfield | 0 | – | 8 | $2.7M | Mar 19, 2026 |
| Neervannan Seshadri | 0 | – | 5 | $1.6M | Mar 20, 2026 |
| Jeffrey S. Farrow | 0 | – | 4 | $1.3M | Jun 16, 2026 |
| Mottiwala Aziz | 0 | – | 3 | $893K | Mar 19, 2026 |
| Wahl Bryan | 0 | – | 3 | $850K | Mar 19, 2026 |
| Lin Elizabeth Yeu | 0 | – | 4 | $243K | Mar 19, 2026 |
| Goodrich Katherine | 0 | – | 1 | $183K | Jun 15, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| DEEP Track Capital, LP | 8.5% | 13G | May 15, 2026 | filing ↗ | |
| DEEP Track Biotechnology Master Fund, Ltd. | 8.5% | 13G | May 15, 2026 | filing ↗ | |
| David Kroin | 8.5% | 13G | May 15, 2026 | filing ↗ | |
| RTW Investments, LP | 8.1% | 13G | Aug 14, 2025 | filing ↗ | |
| Roderick Wong | 8.1% | 13G | Aug 14, 2025 | filing ↗ | |
| Blackrock, Inc. | 7.4% | 13G | Apr 24, 2025 | filing ↗ | |
| Janus Henderson Group PLC | 5.3% | 13G | May 15, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Bobak Azamian | $615K | Jun 17, 2026 | filing ↗ |
| Jeffrey S. Farrow | $877K | Jun 16, 2026 | filing ↗ |
| Goodrich Katherine | $183K | Jun 15, 2026 | filing ↗ |
| William J Link | $776K | Jun 15, 2026 | filing ↗ |
| Neervannan Seshadri | $200K | Mar 20, 2026 | filing ↗ |
| Jeffrey S. Farrow | $146K | Mar 19, 2026 | filing ↗ |
| Mottiwala Aziz | $297K | Mar 19, 2026 | filing ↗ |
| Bobak R. Azamian | $802K | Mar 19, 2026 | filing ↗ |
| Dianne C. Whitfield | $280K | Mar 19, 2026 | filing ↗ |
| Wahl Bryan | $283K | Mar 19, 2026 | filing ↗ |
| Neervannan Seshadri | $307K | Mar 19, 2026 | filing ↗ |
| Lin Elizabeth Yeu | $26K | Mar 19, 2026 | filing ↗ |
| Dianne C. Whitfield | $280K | Mar 18, 2026 | filing ↗ |
| Wahl Bryan | $283K | Mar 18, 2026 | filing ↗ |
| Bobak R. Azamian | $802K | Mar 18, 2026 | filing ↗ |
| Neervannan Seshadri | $248K | Mar 18, 2026 | filing ↗ |
| Jeffrey S. Farrow | $147K | Mar 18, 2026 | filing ↗ |
| Mottiwala Aziz | $298K | Mar 18, 2026 | filing ↗ |
| Lin Elizabeth Yeu | $26K | Mar 18, 2026 | filing ↗ |
| Bobak R. Azamian | $762K | Mar 17, 2026 | filing ↗ |
| Neervannan Seshadri | $217K | Mar 17, 2026 | filing ↗ |
| Jeffrey S. Farrow | $147K | Mar 17, 2026 | filing ↗ |
| Wahl Bryan | $283K | Mar 17, 2026 | filing ↗ |
| Dianne C. Whitfield | $280K | Mar 17, 2026 | filing ↗ |
| Lin Elizabeth Yeu | $26K | Mar 17, 2026 | filing ↗ |
| Mottiwala Aziz | $298K | Mar 17, 2026 | filing ↗ |
| William J Link | $860K | Mar 16, 2026 | filing ↗ |
| Neervannan Seshadri | $641K | Mar 4, 2026 | filing ↗ |
| Dianne C. Whitfield | $1.3M | Jan 2, 2026 | filing ↗ |
| Bobak Azamian | $495K | Dec 24, 2025 | filing ↗ |
| Lin Elizabeth Yeu | $165K | Dec 16, 2025 | filing ↗ |
| Dianne C. Whitfield | $592K | Dec 16, 2025 | filing ↗ |
| William Link | $846K | Dec 15, 2025 | filing ↗ |
| William J Link | $1.0M | Dec 15, 2025 | filing ↗ |
| Bobak Azamian Living Trust | $332K | Sep 24, 2025 | filing ↗ |
| Link William J Phd | $1.5M | Sep 8, 2025 | filing ↗ |
| Bobak R. Azamian | $300K | Aug 11, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Officer/director changes (5.02) | Jul 13, 2026 | filing ↗ |
| Material agreement (1.01) | Jul 6, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Jul 6, 2026 | filing ↗ |
| Other events (8.01) | Jul 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 6, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 25, 2026 | filing ↗ |
| Earnings (2.02) | May 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 6, 2026 | filing ↗ |
| Earnings (2.02) | Feb 23, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 23, 2026 | filing ↗ |
| Officer/director changes (5.02) | Feb 18, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 18, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 12, 2026 | filing ↗ |
| Earnings (2.02) | Nov 4, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 4, 2025 | filing ↗ |
| Earnings (2.02) | Aug 6, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 6, 2025 | filing ↗ |